Phase I
Participants:
20–100 healthy volunteers
Purpose:
- Safety
- Dose determination
Phase II
Participants:
100–300 patients
Purpose:
- Preliminary effectiveness
- Safety
Phase III
Participants:
Large populations
Purpose:
- Confirm efficacy
- Support regulatory submission
Phase IV
Conducted after approval.
Purpose:
- Long-term monitoring